Benefits of fish oil supplementation for hemodialysis patients

Journal of the American Dietetic Association

Volumn 103, Issue 9, 2003, Pages 1174-1177

  Vergili Nelsen, Joyce Marcley ^a  

^a 37 Deer Run Road ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CARBON; ALPHA TOCOPHEROL; ANTIHISTAMINIC AGENT; CAPSAICIN; COROMEGA; DOCOSAHEXAENOIC ACID; ERYTHROPOIETIN; FISH OIL; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; HEPARIN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; RETINOL; SAFFLOWER OIL; WARFARIN; SERUM ALBUMIN;

BLEEDING; BLEEDING TIME; CLINICAL TRIAL; DIETITIAN; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GRAFT PATENCY; HEALTH; HEALTH CARE COST; HEART PROTECTION; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MORTALITY; PHYSICIAN; PRURITUS; REVIEW; SIDE EFFECT; THROMBOSIS; TOXICITY; VASCULAR ACCESS; WELLBEING; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; FEMALE; INDWELLING CATHETER; MALE; METABOLISM; RENAL REPLACEMENT THERAPY; SEA FOOD;

ALLIUM SATIVUM; CARTHAMUS TINCTORIUS; GINKGO BILOBA;

CARDIOVASCULAR DISEASES; CATHETERS, INDWELLING; DIETARY SUPPLEMENTS; ERYTHROPOIETIN; FEMALE; FISH OILS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PRURITUS; RENAL DIALYSIS; SEAFOOD; SERUM ALBUMIN; THROMBOSIS;

EID: 0142089773     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(03)00984-2     Document Type: Article

References (26)

1. Donadio J. The role of omega-3 fatty acids in the practice of nephrology. 2002;. Presented at: National Kidney Foundation Clinical Nephrology meeting; April 18, Chicago, IL
2. Food and Drug Administration Web site. 2003;. Available at: http://www.cfsan.fda.gov. Accessed August 5
3. Tamimi N.A., Mikhail A.I., Stevens P.E. Role of gamma-linolenic acid in uremic pruritus. Nephron. 83:1999;170-171
4. Murphy K., Carmichael A.J. Renal itch. Clin Exper Dermat. 25:2000;103-106
5. Goicoechea M., de Sequera P., Ochando A., Andrea C., Caramelo C. Uremic pruritus An unresolved problem in hemodialysis patients. Nephron. 82:1999;73-74
6. Peck L., Monsen E., Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations and pruritus symptoms in hemodialysis patients. Am J Clin Nutr. 64:1996;210-214
7. Hawkins R. Observations of an emulsified fish oil supplement in a dialysis population. JANA. 5:2002;4-5
8. Yoshimoto-Furuie K., Yoshimoto K., Tanaka T., Saima S., Kikuchi Y., Shay J., Horrobin D.F., Echizen H. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron. 81:1999;151-159
9. Jones W.L., Kaiser S.P. Pilot study An emulsified fish oil supplement significantly improved C-reactive protein, hemoglobin, albumin and urine output in chronic hemodialysis volunteers. JANA. 5:2002;45-50
10. Holman R. The slow discovery of the importance of omega-3 essential fatty acids in human health. J Nutr. 128:1998;427S-433S
11. Lossl K., Skou H.A., Christensen J.H., Schmidt E.B. The effect of omega-3 fatty acids on neutrophils in patients on hemodialysis. Lipids. 34:1999;S185
12. Schmitz P., McClound L., Reikes S., Leonard C.L., Gellens M.E. Prophylaxis of hemodialysis graft thrombosis with fish oil Double-blind, randomized, prospective trial. J Am Soc Nephrol. 13:2002;184-190
13. Donadio J. Omega-3 fatty acids and their role in nephrologic practice. Curr Opin Nephrol Hypertens. 10:2001;639-642
14. Diskin C., Stokes T., Pennell A. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis. Nephron. 64:1993;1-26
15. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willet W.C., Jing M. Blood levels of long chain omega-3 fatty acids and the risk of sudden death. N Engl J Med. 346:2002;1113-1118
16. GISSI-Prevencione Investigators. Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E after myocardial infarction results of the GISSI-Prevencione trial. Lancet. 354:1999;447-455
17. vonSchacky C., Angerer P., Kothny W., Karl T., Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 130:1999;554-562
18. Ando M., Sanaka T., Nihei H. Eicosapentanoic acid reduced plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol. 10:1999;2177-2184
19. Dionisio P., Caramello E., Bergia R., Valenti M., Cornella C., Pagni R., Bajardi P. Atherogenic risk in patients undergoing regular dialysis treatment improvement of lipid patterns and lipoproteins by polyunsaturated omega-3 fatty acids (letter). Nephrol Dial Transplant. 9:1994;458
20. Rolf N., Tenschert W., Lison A.E. Results of a long-term administration of omega-3 fatty acids in haemodialysis patients with dyslipoproteinaemia. Nephrol Dial Transplant. 5:1990;797-801
21. Kutner N.G., Clow P.W., Zhang R., Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis. 39:2002;1018-1024
22. Hombrouckx R.O., Bogaert A.M., Leroy F.M., De Vos J.Y., Vermaercke N.M., Picavet L.M., Larno L.A. Polyunsaturated fatty acids of the omega-3 class in chronic dialysis. ASAIO J. 38:1992;M331-M333
23. Donnelly S.M., Ali M.A., Churchill D.N. Effect of omega-3 fatty acids from fish oil on hemostasis, blood pressure and lipid profile of dialysis patients. J Am Soc Nephrol. 2:1992;1634-1639
24. Sarubin A. The Health Professional's Guide to Popular Dietary Supplements. 2000;118-130 American Dietetic Association, Chicago, IL. 148-158
25. Food and Drug Administration's Center for Food Safety and Applied Nutrition Consumer Advisory Web site. 2003;. Available at: http://www.cfsan.fda. gov/∼dms/admehg.html. Accessed August 5
26. Donadio J. The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy. J Renal Nutr. 11:2001;122-128